InsiderClue
Stocks · Health care · Pharmaceutical Preparations

AbbVie

ABBV Clue Score27
United States Fiscal year ends December CIK 0001551152 Results filed 30 Oct 2026
Add to watchlist

What the insiders did Net selling

By person

36 insiders · 328 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Richard A Gonzalez
Director
—
$233.01M (58) scheduled
−$233.01M
392,379
$98.09M
+24.5%
Michael Severino
Vice Chairman
—
$104.33M (22) scheduled
−$104.33M
152,103
$38.03M
+85.8%
Timothy J. Richmond
EVP, Chief HR Officer
—
$71.94M (29) scheduled
−$71.94M
6,130
$1.53M
−35.1%
Laura J Schumacher
Vice Chairman
$1.76M (1)
$61.93M (25) scheduled
−$60.17M
248,002
$62.00M
—
Jeffrey Ryan Stewart
EVP, Chief Commercial Officer
$1.00M (1)
$45.08M (15) scheduled
−$44.08M
83,171
$20.79M
+182.1%
Azita Saleki-Gerhardt
EVP, Chief Operations Officer
—
$41.42M (18) scheduled
−$41.42M
201,667
$50.42M
+274.1%
Carlos Alban
Vice Chairman
—
$32.57M (9) scheduled
−$32.57M
114,899
$28.72M
−23.1%
Henry O Gosebruch
EVP, Chief Strategy Officer
$2.02M (1)
$29.66M (46)
−$27.64M
216,735
$54.18M
+1.9%
Perry C Siatis
EVP, GC and Secretary
—
$24.22M (18) scheduled
−$24.22M
4,619
$1.15M
−55.5%
Robert A. Michael
Chairman of The Board and CEO
—
$20.10M (10) scheduled
−$20.10M
178,737
$44.68M
+718.5%
Elaine K. Sorg
SVP, US Commercial Operations
—
$15.64M (18) scheduled
−$15.64M
35,330
$8.83M
+100.8%
William J Chase
EVP, Finance & Administration
$2.05M (1)
$16.61M (5)
−$14.56M
169,552
$42.39M
−1.6%
Nicholas Donoghoe
EVP, Chief Bus/Strat Officer
$498.06K (1)
$14.98M (5) scheduled
−$14.49M
74,430
$18.61M
+64.7%
Scott T Reents
EVP, Chief Financial Officer
—
$8.70M (4)
−$8.70M
38,777
$9.69M
+4,693%
Carrie C Strom
SVP & Pres Global Allerg Aesth
—
$5.73M (9) scheduled
−$5.73M
28,024
$7.01M
—
Kevin K Buckbee
SVP, Controller
—
$5.07M (4) scheduled
−$5.07M
7,797
$1.95M
+82.7%
Roxanne S Austin
Director
$5.06M (4)
$9.88M (5)
−$4.82M
39,576
$9.89M
+44.9%
Brian L Durkin
VP, Controller
$255.75K (3)
$4.35M (4) scheduled
−$4.09M
33,149
$8.29M
+556.3%
David Ryan Purdue
SVP, Controller
—
$1.22M (1)
−$1.22M
2,654
$663.50K
−41.1%
Edward J Rapp
Director
$1.14M (4)
—
+$1.14M
56,352
$14.09M
+141.4%
Glenn F Tilton
Director
$496.27K (1)
—
+$496.27K
51,564
$12.89M
+73.8%
Thomas A. Hurwich
VP, Controller
—
$335.23K (4) scheduled
−$335.23K
62,329
$15.58M
+1.4%
Thomas C Freyman
Director
—
—
—
127,869
$31.97M
+11.4%
Thomas J Hudson
SVP, CSO, Global Research
—
—
—
107,267
$26.82M
+741.4%
Roopal Thakkar
EVP, R&D and CSO
—
—
—
52,376
$13.09M
+122.7%
Robert J Alpern
Director
—
—
—
35,646
$8.91M
+87.4%
Frederick H Waddell
Director
—
—
—
30,076
$7.52M
+141.4%
William H.l. Burnside
Director
—
—
—
28,076
$7.02M
+168.4%
Edward M Liddy
Director
—
—
—
26,683
$6.67M
+71.3%
Brett J Hart
Director
—
—
—
20,590
$5.15M
+592.3%
Melody B Meyer
Director
—
—
—
17,616
$4.40M
—
Rebecca B Roberts
Director
—
—
—
14,846
$3.71M
—
Demetris D Crum
EVP, Chief HR Officer
—
—
—
7,914
$1.98M
+12.3%
Susan E Quaggin
Director
—
—
—
3,643
$910.75K
—
Jennifer L. Davis
Director
—
—
—
3,643
$910.75K
—
Thomas J Falk
Director
—
—
—
2,321
$580.25K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.